A phase II−III trial of olesoxime in subjects with amyotrophic lateral sclerosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A phase II−III trial of olesoxime in subjects with amyotrophic lateral sclerosis

Published:2014-01-21 Issue:3 Volume:21 Page:529-536
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Eur J Neurol

Author:

Lenglet T.¹,Lacomblez L.¹²,Abitbol J. L.³,Ludolph A.⁴,Mora J. S.⁵,Robberecht W.⁶⁷,Shaw P. J.⁸,Pruss R. M.³,Cuvier V.³,Meininger V.¹,

Affiliation:

1. Département de Neurologie; Centre de référence de la SLA; APHP; Hôpital de la Salpêtrière; Paris France

2. Centre d'Investigation Clinique Pitié -Neurosciences; CIC-1422, APHP, INSERM, ICM Hôpital de la Salpêtriére Paris France

3. TROPHOS; Parc Scientifique de Luminy; Marseille France

4. Department of Neurology; University of Ulm; Ulm Germany

5. Department of Neurology; Hospital Carlos III; Madrid Spain

6. Laboratory of Neurobiology; Vesalius Research Center; VIB; Leuven Belgium

7. Department of Neurology; University Hospital Leuven; Leuven Belgium

8. Sheffield Institute for Translational Neuroscience (SITraN); University of Sheffield; Sheffield South Yorkshire UK

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ene.12344/fullpdf

Reference26 articles.

1. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II;Lacomblez;Lancet,1996

2. Emerging targets and treatments in amyotrophic lateral sclerosis;Zinman;Lancet Neurol,2011

3. Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis;Bordet;J Pharmacol Exp Ther,2007

4. Apoptosis in amyotrophic lateral sclerosis - what is the evidence?;Sathasivam;Lancet Neurol,2005

5. Specific antinociceptive activity of cholest-4-en-3-one, oxime (TRO19622), in experimental models of painful diabetic and chemotherapy-induced neuropathy;Bordet;J Pharmacol Exp Ther,2008

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The mitochondrial translocator protein (TSPO) in Alzheimer's disease: Therapeutic and immunomodulatory functions;Biochimie;2024-09

2. Pore-Forming VDAC Proteins of the Outer Mitochondrial Membrane: Regulation and Pathophysiological Role;Biochemistry (Moscow);2024-06

3. Acceptance and Commitment Therapy plus usual care for improving quality of life in people with motor neuron disease (COMMEND): a multicentre, parallel, randomised controlled trial in the UK;The Lancet;2024-06

4. Current therapy in amyotrophic lateral sclerosis (ALS): A review on past and future therapeutic strategies;European Journal of Medicinal Chemistry;2024-06

5. Revisiting Glutamate Excitotoxicity in Amyotrophic Lateral Sclerosis and Age-Related Neurodegeneration;International Journal of Molecular Sciences;2024-05-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3